Whitepaper Oct 7, 2026 Finding Common Ground: A Practical Framework for Multi-Stakeholder Co-Creation
Press Release Oct 22, 2026 Lumanity Unveils AI-Enabled Intelligence Platform Engineered to Transform Value Demonstration Across the Lifecycle of a Medicine
Press Release Jul 7, 2026 Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets initiative) Validation For Near-Term Emissions Reduction Targets
Whitepaper Oct 7, 2026 Finding Common Ground: A Practical Framework for Multi-Stakeholder Co-Creation
Press Release Oct 22, 2026 Lumanity Unveils AI-Enabled Intelligence Platform Engineered to Transform Value Demonstration Across the Lifecycle of a Medicine
Press Release Jul 7, 2026 Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets initiative) Validation For Near-Term Emissions Reduction Targets
Case Study Jun 29, 2022 From Discovery to Proof of Concept: Early Asset Framework Mapping in Commercial Strategy Development
Case Study Jun 14, 2022 Platform Assessment, Indication Prioritization & TPP Development to Inform Development Plan and Competitive Differentiation
Case Study Jun 12, 2022 Clinical Validation, TPP Refinement and Value Assessment of iPSC derived Cell Therapies
Case Study May 12, 2022 Strategic Development of Gene-Editing Platform Technology in Rare Disease Space
Case Study Apr 11, 2022 Top Multinational Pharma Interested in Assessing/Onboarding ACT and/or Other IO Modalities; IO Landscape, Portfolio Gap Analysis, and BD Strategy Assessment
Case Study Mar 25, 2022 Multivariate Prioritization of Putative Targets, Indications and Specific Therapeutic Modalities
Case Study Mar 11, 2022 Public Preclinical Biotech with Differentiated ACT Platform in Need of Strategic Focus; Assessment/Prioritization of Putative Targets, Indications, and Enabling Tech
Case Study Mar 2, 2022 Platform Assessment, Indication Prioritization and Target Product Profile Development to Inform Development Plan and Competitive Differentiation
Case Study Feb 25, 2022 Portfolio Strategy and Opportunity Assessment to Support BD Decisions and Clinical Development
Case Study Feb 18, 2022 Modeling To Inform Payer Communications and Policy – Optimizing Treatment Sequences in Multiple Immunology Indications